Skip to content
by Legal Desire
18 April 2023

Latham & Watkins Advises Prometheus Biosciences in US$10.8 Billion Acquisition by Merck

Advising firms

Deal team

21 lawyers named
LawyerFirmSeniorityPracticeOffice
Daniel Rees Lead Latham & Watkins LLP Partner corporate Orange County
Matthew Bush Latham & Watkins LLP Partner corporate San Diego
Cheston Larson Latham & Watkins LLP Partner corporate San Diego
Brian Umanoff Latham & Watkins LLP Associate corporate Not stated
Abby Timmons Latham & Watkins LLP Associate corporate Not stated
Jack McKay Latham & Watkins LLP Associate corporate Not stated
Jack Vanderford Latham & Watkins LLP Associate corporate Not stated
Holly Bauer Latham & Watkins LLP Partner benefits and compensation San Diego
Laura Szarmach Latham & Watkins LLP Counsel benefits and compensation Washington, D.C.
Julie Voorhes Latham & Watkins LLP Associate benefits and compensation Not stated
Ben Haas Latham & Watkins LLP Partner regulatory Washington, D.C.
Betty Pang Latham & Watkins LLP Partner regulatory Bay Area
Chad Jennings Latham & Watkins LLP Counsel regulatory Washington, D.C.
Josh Holian Latham & Watkins LLP Partner antitrust Bay Area
Kevin Wu Latham & Watkins LLP Associate antitrust Not stated
Chris Hazuka Latham & Watkins LLP Partner intellectual property Bay Area
Robert Yeh Latham & Watkins LLP Associate intellectual property Not stated
Kristina Funahashi Latham & Watkins LLP Associate intellectual property Not stated
Samuel Weiner Latham & Watkins LLP Partner tax Century City
Seung (Sam) Yang Latham & Watkins LLP Associate tax Not stated
Heather Deixler Latham & Watkins LLP Partner data privacy Bay Area

18 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.

REGISTER FREE SIGN IN

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value
USD 10.8bn (US$10.8 billion)
What the figure measures
Total transaction value
Client
Prometheus Biosciences, Inc.Sell-side
Counterparties
Merck (Buy-side)